(2021). IS26-mediated amplification of blaOXA-1and blaCTX-M-15with concurrent outer membrane porin disruption associated with de novo carbapenem resistance in a recurrent bacteraemia cohort.
Chicago Style (17th ed.) CitationIS26-mediated Amplification of BlaOXA-1and BlaCTX-M-15with Concurrent Outer Membrane Porin Disruption Associated with De Novo Carbapenem Resistance in a Recurrent Bacteraemia Cohort. 2021.
MLA (8th ed.) CitationIS26-mediated Amplification of BlaOXA-1and BlaCTX-M-15with Concurrent Outer Membrane Porin Disruption Associated with De Novo Carbapenem Resistance in a Recurrent Bacteraemia Cohort. 2021.
Warning: These citations may not always be 100% accurate.